₹86.72
▼ -1.64 -1.86%
17 Jul 2026
NSE Listed
Niva Bupa Health Ins Co Limited (NIVABUPA)
20-day avg volume: 16.9L shares
- Company is almost debt-free.
- Company is loss-making at the latest annual result.
- Stock trades at a high P/E of 67.
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| EBITDA | — | — | — | — | — | — | — | — |
| Net Profit | — | — | — | — | — | — | — | — |
| EPS | — | — | — | — | — | — | — | — |
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | ₹6,472 Cr |
| EBITDA | — | — | — | — | ₹0 Cr |
| Net Profit | ₹-197 Cr | ₹13 Cr | ₹82 Cr | ₹214 Cr | ₹131 Cr |
| EPS | -1.42 | 0.08 | 0.5 | 1.2 | — |
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | — | — | — | — | ₹11,276 Cr |
| Total Liabilities | — | — | — | — | ₹8,077 Cr |
| Equity | — | — | — | — | ₹3,199 Cr |
| Total Debt | ₹250 Cr | ₹250 Cr | ₹250 Cr | ₹250 Cr | ₹250 Cr |
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Operating | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investing | ₹-723 Cr | ₹-829 Cr | ₹-1,882 Cr | ₹-2,348 Cr |
| Financing | ₹374 Cr | ₹280 Cr | ₹1,110 Cr | ₹771 Cr |
| Free Cash Flow | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Financial Services · Insurance - Life
Niva Bupa Health Insurance Company Limited provides health insurance products in India. It offers health insurance plans, such as individual, family, NRIs, senior citizens, personal accident, critical illness; travel insurance, including international and studying abroad insurance plans; and corporate insurance comprising group and start up health, group personal accident and OPD coverage, and group health insurance claim process. The company was formerly known as Max Bupa Health Insurance Company Limited and changed its name to Niva Bupa Health Insurance Company Limited in July 2021. The company was founded in 1947 and is based in Gurugram, India. Niva Bupa Health Insurance Company Limited is a subsidiary of Bupa Singapore Holdings Pte. Ltd.
www.nivabupa.com ↗As of 2026-03-31
Quarterly — figures in %. Latest 9 quarters.
| Period | Jun 2024 | Nov 2024 | Nov 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Promoters | 62.9% | 56% | 56% | 56% | 56% | 55.4% | 55.4% | 55.4% | 55.4% |
| FIIs | 0% | 8.6% | 8.6% | 8.8% | 8.9% | 10.8% | 10.7% | 10.3% | 10.6% |
| DIIs | 0% | 9.6% | 9.6% | 9.8% | 9.7% | 15.1% | 15.3% | 16% | 16.5% |
| Public | 37.1% | 25.8% | 25.8% | 25.4% | 25.4% | 18.7% | 18.6% | 18.3% | 17.6% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 86 | 1,60,440 | 1,60,440 | 1,46,255 | 1,36,017 | 1,54,883 | 1,58,550 | 1,47,718 | 1,35,343 |
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
| Name | Category | Stake | Shares |
|---|---|---|---|
| Bupa Singapore Holdings Pte Ltd | Shareholding of Promoter and Promoter Group | 55.4% | 102.27 Cr |
| Fettle Tone Llp | Public Shareholding | 7.9% | 14.62 Cr |
| Dsp Mutual Fund Through Various Schemes | Public Shareholding | 3.2% | 5.92 Cr |
| India Business Excellence Fund Iv | Public Shareholding | 2.6% | 4.84 Cr |
| Nippon India Mutual Fund Through Various Schemes | Public Shareholding | 2.5% | 4.66 Cr |
| V-sciences Investments Pte Ltd | Public Shareholding | 2.4% | 4.47 Cr |
| Amansa Holdings Private Limited | Public Shareholding | 2.3% | 4.23 Cr |
| A91 Emerging Fund Ii Llp | Public Shareholding | 2.1% | 3.90 Cr |
| Zulia Investments Pte. Ltd. | Public Shareholding | 2% | 3.78 Cr |
| Tata Mutual Fund Through Various Schemes | Public Shareholding | 1.5% | 2.76 Cr |
| Sbi Mutual Fund Through Various Schemes | Public Shareholding | 1.4% | 2.57 Cr |
| M Pallonji And Co Pvt Ltd | Public Shareholding | 1.2% | 2.13 Cr |
| Bupa Capability Centre Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Bupa Investments Overseas Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| 4dent Sp. Z.o.o. | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Advanced Skincare S.l. | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Amedex Services Ltd. (st Kitts) | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Anglolab S. A | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Benefit Pocket Pty Ltd | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Bupa Administracion Y Servicios Spa | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Bupa Aged Care Australasia Pty Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Bupa Aged Care Australia Holdings Pty Ltd | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Bupa Aged Care Australia Pty Ltd | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Bupa Aged Care Holdings Pty Ltd | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Bupa Aged Care Property No.2 Trust | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Bupa Capability Centre Private Limited | 0 | 0% | 2026-03-31 |
| Bupa Singapore Holdings Pte Ltd | 0 | 0% | 2026-03-31 |
| Bupa Investments Overseas Limited | 0 | 0% | 2026-03-31 |
| 4dent Sp. Z.o.o. | 0 | 0% | 2026-03-31 |
| Advanced Skincare S.l. | 0 | 0% | 2026-03-31 |
| Amedex Services Ltd. (st Kitts) | 0 | 0% | 2026-03-31 |
| Anglolab S. A | 0 | 0% | 2026-03-31 |
| Benefit Pocket Pty Ltd | 0 | 0% | 2026-03-31 |
| Bupa Administracion Y Servicios Spa | 0 | 0% | 2026-03-31 |
| Bupa Aged Care Australasia Pty Limited | 0 | 0% | 2026-03-31 |
| Bupa Aged Care Australia Holdings Pty Ltd | 0 | 0% | 2026-03-31 |
| Bupa Aged Care Australia Pty Ltd | 0 | 0% | 2026-03-31 |
| Name | Designation | Year |
|---|---|---|
| C B Bhave | Chairman & Independent Director | 2025 |
| RAMACHANDRAN KRISHNAN | Managing Director & Chief Executive Officer | 2025 |
| Geeta Dutta Goel | Independent Director | 2025 |
| David Martin Fletcher | Non Executive Director | 2025 |
| Sridhar Srinivasan | Independent Director | 2025 |
| Mohit Gupta | Independent Director | 2025 |
| Milind Barve | Independent Director | 2025 |
| Vishwanath Mahendra | Whole Time Director & Chief Financial Officer | 2025 |
| Ankur Kharbanda | Whole Time Director / Chief Business officer | 2025 |
| Vivek Karve | Additional Director | 2025 |
| Ashwani Bhatia | Chairman & Additional Director | 2025 |
| Segment | Revenue | Share |
|---|---|---|
| Health | ₹577 Cr | 99.8% |
| Personal Accident | ₹1 Cr | 0.2% |
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 5,000 | 1,827 | 1,827 |
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 17 | 0 | 29 |
| 2025 | 0 | 0 | 0 | 9 | 0 | 9 |
| 2025 | 0 | 0 | 0 | 8 | 0 | 8 |
10 recent disclosure(s)
2 disclosure(s)
📍 C-98 1st Flr Lajpat Nagar, Part 1 South Delhi, New Delhi, New Delhi, 110024
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search